EcoDrugPlus

Atr Serine/threonine Kinase

Ensembl ID : ENSCHAG00000017869
Gene Symbol: ATR
1 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSCHAG00000007181
Gene Symbol: AXL
1 Cross references
188 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCHAG00000026762
Gene Symbol: BRAF
3 Cross references
220 Possible Orthologues:

B1 Bradykinin Receptor-Like

Ensembl ID : ENSCHAG00000004102
Gene Symbol: LOC105895793
3 Cross references
148 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSCHAG00000014960
Gene Symbol: BCL2
3 Cross references
172 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSCHAG00000014465
Gene Symbol: BCL2L1
1 Cross references
229 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSCHAG00000003253
Gene Symbol: BCL2L10
3 Cross references
129 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSCHAG00000005911
Gene Symbol: BCR
1 Cross references
209 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSCHAG00000019204
Gene Symbol: BTK
3 Cross references
204 Possible Orthologues:

C-X-C Chemokine Receptor Type 4-Like

Ensembl ID : ENSCHAG00000004341
Gene Symbol: LOC105912404
3 Cross references
202 Possible Orthologues:

C-X-C Motif Chemokine Receptor 1

Ensembl ID : ENSCHAG00000002214
Gene Symbol: CXCR1
3 Cross references
275 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSCHAG00000025343
Gene Symbol: CXCR4
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).